Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 381
Filter
1.
Neuroscience ; 169(3): 1462-72, 2010 Sep 01.
Article in English | MEDLINE | ID: mdl-20594945

ABSTRACT

Vomeronasal neurons undergo continuous neurogenesis throughout development and adult life. These neurons originate as stem cells in the apical zone of the lumen of the vomeronasal organ (VNO) and are described as nestin-expressing glia-like progenitor cells (Murdoch and Roskams, 2008). They then migrate horizontally along the basal zone where they differentiate into functional VNO neurons (Kaba et al., 1988). We harvested progenitor cells from the adult VNO and, after 3-6 months of invitro culture, these VNO neurons remained in a stable undifferentiated state expressing nestin, beta-tubulin III and vomeronasal type 2 (V2r), but not vomeronasal type 1 (V1r) receptors. Application of histone-deacetylase inhibitors induced development of a neural phenotype that expressed V2r receptors, a down-regulation of nestin expression and no change in any specific genetic markers associated with glial cells. Treatment with valproic acid induced extensive changes in gene expression in the axon guidance pathway. The adult VNO is known to functionally adapt throughout life as a consequence of changes in both a mouse's physiological status and its social environment. These pluripotent cultured neurons may provide valuable insights into how changes in both physiology and environment, exert epigenetic effects on vomeronasal neurons as they undergo continuous neurogenesis and development throughout the life of a mouse.


Subject(s)
Epigenesis, Genetic , Histone Deacetylase Inhibitors/pharmacology , Histone Deacetylases/metabolism , Neural Stem Cells/metabolism , Neurons/metabolism , Receptors, Pheromone/biosynthesis , Vomeronasal Organ/cytology , Animals , Cell Differentiation , Cells, Cultured , Female , Gene Expression Profiling , Genetic Markers , Hydroxamic Acids/pharmacology , Mice , Microtubule-Associated Proteins/biosynthesis , Neural Stem Cells/cytology , Neural Stem Cells/drug effects , Neurons/cytology , Neurons/drug effects , Oligonucleotide Array Sequence Analysis , Receptors, Pheromone/genetics , Transcription, Genetic , Valproic Acid/pharmacology , Vomeronasal Organ/metabolism
2.
Brain Res ; 1152: 10-6, 2007 Jun 04.
Article in English | MEDLINE | ID: mdl-17433807

ABSTRACT

The vesicular monoamine transporter type 2 (VMAT2) packages pre-synaptic monoamines into vesicles. Previously, we generated mice hypomorphic for the VMAT2 gene (Slc18a2), which results in a approximately 95% reduction in VMAT2 protein, disrupted vesicular storage, severe depletion of striatal dopamine and mice with moderate motor behaviour deficits. Dopamine released from mid-brain dopamine neurons acts on post-synaptic type 1 (D1) and 2 (D2) receptors located on striatal medium spiny neurons to initiate a signalling cascade that leads to altered transcription factor activity, gene expression and neuronal activity. We investigated striatal gene expression changes in VMAT2hypo mice by quantitative real-time PCR and in situ hybridisation. Despite unaltered expression of D1 and D2 dopamine receptors, there were dramatic alterations in striatal mRNAs encoding the neuropeptides substance P, dynorphin, enkephalin and cholecystokinin. The promoters of these genes are regulated by a combination of transcription factors that includes cAMP responsive element binding protein-1 (CREB) and c-Fos. Indeed, the changes in peptide mRNAs were associated with elevated expression of Creb1 and c-Fos. These data indicate that striatal dopamine depletion, as a consequence of deficient vesicular storage in this mouse, triggers a complex program of gene expression, consistent with this mouse being an excellent model of Parkinson's disease.


Subject(s)
Corpus Striatum/metabolism , Gene Expression , Vesicular Monoamine Transport Proteins/biosynthesis , Animals , Cyclic AMP Response Element-Binding Protein/biosynthesis , Cyclic AMP Response Element-Binding Protein/genetics , Disease Models, Animal , Gene Expression Profiling , In Situ Hybridization , Mice , Mice, Inbred C57BL , Neuropeptides/biosynthesis , Neuropeptides/genetics , Parkinsonian Disorders/genetics , Polymerase Chain Reaction , Proto-Oncogene Proteins c-fos/biosynthesis , Proto-Oncogene Proteins c-fos/genetics , RNA, Messenger/biosynthesis , Receptors, Dopamine D1/biosynthesis , Receptors, Dopamine D1/genetics , Receptors, Dopamine D2/biosynthesis , Receptors, Dopamine D2/genetics , Vesicular Monoamine Transport Proteins/genetics
3.
Neuropharmacology ; 43(6): 966-78, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12423666

ABSTRACT

We report here that human Ntera-2/D1 (NT-2) cells, an undifferentiated committed neuronal progenitor cell line, endogenously express a functional P2Y(1) receptor, while other P2Y subtypes, except perhaps P2Y(4), are not functionally expressed. Quantitative RT-PCR analysis showed that NT-2 cells abundantly express mRNA for P2Y(1) and P2Y(11) receptors, while P2Y(2) and P2Y(4) receptors were detected at considerably lower levels. Western blot analysis also demonstrated expression of P2Y(1) receptors and Galpha(q/11) subunits. Various nucleotides induced intracellular Ca(2+) mobilisation in NT-2 cells in a concentration-dependent manner with a rank order potency of 2-MeSADP > 2-MeSATP > ADP > ATP > UTP > ATPgammaS, a profile resembling that of human P2Y(1) receptors. Furthermore, P2Y(1) receptor-specific (A3P5P) and P2Y-selective (PPADS, suramin) antagonists inhibited adenine nucleotide-induced Ca(2+) responses in a concentration-dependent manner, consistent with expression of a P2Y(1) receptor. Moreover, of seven adenine nucleotides tested, only Bz-ATP and ATPgammaS elicited small increases in cAMP formation suggesting that few, if any, functional P2Y(11) receptors were expressed. P2Y(1) receptor-selective adenine nucleotides, including 2-MeSADP and ADP, also induced concentration-dependent phosphorylation and hence, activation of the extracellular-signal regulated protein kinases (ERK1/2). NT-2 cells, therefore, provide a useful neuronal-like cellular model for studying the precise signalling pathways and physiological responses mediated by a native P2Y(1) receptor.


Subject(s)
Adenosine Diphosphate/analogs & derivatives , Adenosine Triphosphate/analogs & derivatives , Membrane Proteins , Neurons/metabolism , Pyridoxal Phosphate/analogs & derivatives , Receptors, Purinergic P2/metabolism , Stem Cells/metabolism , Adenosine Diphosphate/pharmacology , Adenosine Triphosphate/pharmacology , Antineoplastic Agents/pharmacology , Blotting, Western , Calcium/metabolism , Cell Membrane/metabolism , Cells, Cultured , Cyclic AMP , Fluorescence , GTP-Binding Protein alpha Subunits, Gq-G11 , Heterotrimeric GTP-Binding Proteins/metabolism , Humans , Mitogen-Activated Protein Kinases/drug effects , Mitogen-Activated Protein Kinases/metabolism , Platelet Aggregation Inhibitors/pharmacology , Pyridoxal Phosphate/pharmacology , RNA, Messenger/analysis , Receptors, Purinergic P2/classification , Receptors, Purinergic P2Y1 , Receptors, Purinergic P2Y12 , Receptors, Purinergic P2Y2 , Reverse Transcriptase Polymerase Chain Reaction/methods , Suramin/pharmacology , Thionucleotides/pharmacology , Uridine Triphosphate/pharmacology
5.
Genomics ; 78(3): 124-8, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11735218

ABSTRACT

It has recently been shown that UDP-glucose is a potent agonist of the orphan G-protein-coupled receptor (GPCR) KIAA0001. Here we report cloning and analysis of the rat and mouse orthologs of this receptor. In accordance with GPCR nomenclature, we have renamed the cDNA clone, KIAA0001, and its orthologs GPR105 to reflect their functionality as G-protein-coupled receptors. The rat and mouse orthologs show 80% and 83% amino acid identity, respectively, to the human GPR105 protein. We demonstrate by genomic Southern blot analysis that there are no genes in the mouse or rat genomes with higher sequence similarity. Chromosomal mapping shows that the mouse and human genes are located on syntenic regions of chromosome 3. Further analyses of the rat and mouse GPR105 proteins show that they are activated by the same agonists as the human receptor, responding to UDP-glucose and closely related molecules with similar affinities. The mouse and rat receptors are widely expressed, as is the human receptor. Thus we conclude that we have identified the rat and mouse orthologs of the human gene GPR105.


Subject(s)
GTP-Binding Proteins/metabolism , Receptors, Cell Surface/genetics , Receptors, G-Protein-Coupled , Receptors, Purinergic P2 , Amino Acid Sequence , Animals , Base Sequence , Blotting, Southern , Cloning, Molecular , Humans , Mice , Molecular Sequence Data , Open Reading Frames , Rats , Receptors, Cell Surface/agonists , Receptors, Cell Surface/chemistry , Receptors, Cell Surface/metabolism , Receptors, Purinergic P2Y , Sequence Homology, Amino Acid , Uridine Diphosphate Glucose/pharmacology
6.
J Neurochem ; 79(3): 564-75, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11701760

ABSTRACT

There is extensive experimental evidence indicating a crucial role for glutamate in epileptogenesis and epileptic activity. The glial glutamate transporters GLT1 and GLAST are proposed to account for the majority of extracellular glutamate re-uptake. In the present study, polyclonal antibodies specific to GLT1 and GLAST were generated and characterized, revealing distribution patterns for the two transporters confirming those previously reported. In situ hybridization and immunoblotting were then used to compare levels of these two transporters in the parietal cortex and hippocampus of unstimulated and stimulated EL mice with DDY control mice. Additionally, HPLC determined tissue glutamate concentrations in the same regions of these animals. These experiments revealed reductions in GLT1 mRNA and protein in the parietal cortex of unstimulated and stimulated EL mice compared with DDY controls, accompanied by an increase in tissue glutamate concentration in the stimulated EL mice group. GLT1 mRNA was also reduced in the CA3 hippocampal subfield of both unstimulated and stimulated EL mice. GLAST protein was reduced in the hippocampus of the stimulated EL mice group, while no changes in GLAST mRNA or protein were detected in the parietal cortex of EL mice when compared with DDY controls. The glial glutamate transporter down-regulation reported here may play a role in seizure initiation, spread and maintenance in the EL mouse.


Subject(s)
Amino Acid Transport System X-AG/metabolism , Epilepsy, Temporal Lobe/metabolism , Excitatory Amino Acid Transporter 2/metabolism , Hippocampus/metabolism , Parietal Lobe/metabolism , Amino Acid Transport System X-AG/genetics , Amino Acid Transport System X-AG/immunology , Animals , Antibody Specificity , Blotting, Western , Chromatography, High Pressure Liquid , Excitatory Amino Acid Transporter 2/genetics , Excitatory Amino Acid Transporter 2/immunology , Glutamic Acid/analysis , In Situ Hybridization , Male , Mice , Mice, Inbred Strains , Mice, Mutant Strains , Neuroglia/chemistry , Neuroglia/metabolism , RNA, Messenger/analysis
7.
Biochim Biophys Acta ; 1521(1-3): 107-19, 2001 Oct 31.
Article in English | MEDLINE | ID: mdl-11690642

ABSTRACT

The diverse biological actions of extracellular nucleotides in tissues and cells are mediated by two distinct classes of P2 receptor, P2X and P2Y. The G protein-coupled P2Y receptors comprise at least six mammalian subtypes (P2Y(1,2,4,6,11,12)), all of which have been cloned from human tissues, as well as other species. The P2Y receptor subtypes differ in their pharmacological selectivity for various adenosine and uridine nucleotides, which overlap in some cases. Data concerning the mRNA expression patterns of five P2Y receptors (P2Y(1,2,4,6,11)) in different human tissues and cells are currently quite limited, while P2Y mRNA distribution in the human brain has not previously been studied. In this study, we have addressed this deficiency in receptor expression data by using a quantitative reverse transcription-polymerase chain reaction approach to measure the precise mRNA expression pattern of each P2Y receptor subtype in a number of human peripheral tissues and brain regions, from multiple individuals, as well as numerous human cell lines and primary cells. All five P2Y receptors exhibited widespread yet subtype-selective mRNA expression profiles throughout the human tissues, brain regions and cells used. Our extensive expression data indicate the many potentially important roles of P2Y receptors throughout the human body, and will help in elucidating the physiological function of each receptor subtype in a wide variety of human systems.


Subject(s)
Polymerase Chain Reaction/methods , RNA, Messenger/metabolism , Receptors, Purinergic P2/metabolism , Actins/analysis , Brain/metabolism , Cell Line , Cyclophilins/analysis , DNA Probes , Female , Glyceraldehyde-3-Phosphate Dehydrogenases/analysis , Humans , Male , Protein Isoforms/analysis , Protein Isoforms/metabolism , RNA, Messenger/analysis , Receptors, Purinergic P2/analysis , Reverse Transcriptase Polymerase Chain Reaction
8.
Neuropathology ; 21(3): 162-7, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11666012

ABSTRACT

Previous studies have reported that calcium binding proteins, which have important functions in regulating the intracellular ion concentration, may influence the vulnerability of neurons in neurodegenerative disease. It has been observed that the neurons containing calbindin D28K (CB) may in certain circumstances be more resistant to excitotoxic and ischemic injury. In the present study the susceptibility of hippocampal neurons containing CB to develop NFT was studied, and the distribution of CB cells was compared with hippocampal plaque density in the Alzheimer's disease (AD) brain. Interestingly CB-positive hippocampal neurons did not contain tangles and could be seen next to degenerating tau-positive pyramidal cells. Comparison of the hippocampal plaque distribution with that of CB neurons showed that in general CB-positive neurons were found in areas with a low plaque burden. Further comparison of cases with differing degrees of severity indicated that CB-positive neurons were relatively preserved in cases with moderate plaque and tangle content but that in severe cases the CB-positive pyramidal cells were lost. These findings indicate that CB cells may be protected in the earlier stages of the disease but that this resistance ability is lost in the late stages of AD. The observation that CB-positive pyramidal cells do not accumulate NFT suggests that proteolysis of tau differs in CB-negative and CB-positive cells.


Subject(s)
Alzheimer Disease/metabolism , Hippocampus/metabolism , Neurofibrillary Tangles/metabolism , Plaque, Amyloid/metabolism , Pyramidal Cells/metabolism , S100 Calcium Binding Protein G/metabolism , Age of Onset , Aged , Aged, 80 and over , Aging/metabolism , Aging/pathology , Alzheimer Disease/pathology , Alzheimer Disease/physiopathology , Benzothiazoles , Calbindin 1 , Calbindins , Female , Fluorescent Dyes , Hippocampus/pathology , Humans , Immunohistochemistry , Male , Middle Aged , Neurofibrillary Tangles/pathology , Plaque, Amyloid/pathology , Pyramidal Cells/pathology , Thiazoles
9.
Neuroscience ; 106(2): 275-85, 2001.
Article in English | MEDLINE | ID: mdl-11566500

ABSTRACT

Studies with animal seizure models have indicated that changes in temporal and spatial expression of voltage-gated sodium channels may be important in the pathology of epilepsy. Here, by using in situ hybridisation with previously characterised subtype-selective oligonucleotide probes [Whitaker et al. (2000) J. Comp. Neurol. 422, 123-139], we have compared the cellular expression of all four brain alpha-subunit sodium channel mRNAs in "normal" and epileptic hippocampi from humans. Neuronal cell loss was observed in all regions of the hippocampus of diseased patients, indicating that sclerosis had occurred. Losses of up to 40% compared to post-mortem controls were observed which were statistically significant in all regions studied (dentate gyrus, hilus, and CA1-3). To assess mRNA levels of the different alpha-subtypes in specific subregions, control and diseased tissue sections were hybridised to subtype-specific probes. To quantify any changes in expression while allowing for cell loss, the sections were processed for liquid emulsion autoradiography and grain counts were performed on populations of individual neurones in different subregions. No significant differences were found in the expression of type I and VI mRNAs. In contrast, a significant down-regulation of type II mRNA was observed in the epileptic tissue in the remaining pyramidal cells of CA3 (71+/-7% of control, P<0.01), CA2 (81+/-8% of control, P<0.05) and CA1 (72+/-6% of control, P<0.05) compared with control tissue. Additionally, a significant up-regulation in type III mRNA in epileptic CA4 pyramidal cells (145+/-7% of control, P<0.05) was observed. It is not clear whether these changes play a causal role in human epilepsy or whether they are secondary to seizures or drug treatment; further studies are necessary to investigate these alternatives. However, it is likely that such changes would affect the intrinsic excitability of hippocampal neurones.


Subject(s)
Epilepsy/metabolism , Hippocampus/metabolism , Pyramidal Cells/metabolism , RNA, Messenger/metabolism , Sodium Channels/genetics , Adolescent , Aged , Epilepsy/genetics , Epilepsy/physiopathology , Female , Hippocampus/pathology , Hippocampus/physiopathology , Humans , In Situ Hybridization/methods , Male , Membrane Potentials/genetics , Middle Aged , Nerve Degeneration/etiology , Nerve Degeneration/pathology , Nerve Degeneration/physiopathology , Oligonucleotide Probes , Pyramidal Cells/pathology
10.
Mol Cell Biol ; 21(16): 5321-31, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11463816

ABSTRACT

We have created a transgenic mouse with a hypomorphic allele of the vesicular monoamine transporter 2 (Vmat2) gene by gene targeting. These mice (KA1) have profound changes in monoamine metabolism and function and survive into adulthood. Specifically, these animals express very low levels of VMAT2, an endogenous protein which sequesters monoamines intracellularly into vesicles, a process that, in addition to being important in normal transmission, may also act to keep intracellular levels of the monoamine neurotransmitters below potentially toxic thresholds. Homozygous mice show large reductions in brain tissue monoamines, motor impairments, enhanced sensitivity to dopamine agonism, and changes in the chemical neuroanatomy of the striatum that are consistent with alterations in the balance of the striatonigral (direct) and striatopallidal (indirect) pathways. The VMAT2-deficient KA1 mice are also more vulnerable to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in terms of nigral dopamine cell death. We suggest that the mice may be of value in examining, long term, the insidious damaging consequences of abnormal intracellular handling of monoamines. On the basis of our current findings, the mice are likely to prove of immediate interest to aspects of the symptomatology of parkinsonism. They may also, however, be of use in probing other aspects of monoaminergic function and dysfunction in the brain, the latter making important contributions to the pathogenesis of schizophrenia and addiction.


Subject(s)
Membrane Glycoproteins/genetics , Membrane Transport Proteins , Neuropeptides , Parkinsonian Disorders , Animals , Base Sequence , Biological Transport/genetics , Disease Models, Animal , Gene Expression Regulation , Membrane Glycoproteins/metabolism , Mice , Mice, Transgenic , Molecular Sequence Data , Parkinsonian Disorders/genetics , Parkinsonian Disorders/metabolism , Parkinsonian Disorders/physiopathology , Vesicular Biogenic Amine Transport Proteins , Vesicular Monoamine Transport Proteins
11.
J Chem Neuroanat ; 22(1-2): 79-94, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11470556

ABSTRACT

Global expression profiling techniques such as microarray technology promise to revolutionize biology. Soon it will be possible to investigate alterations at the transcript level of the entire human genome. There is great hope that these techniques will at last shed light on the pathological processes involved in complex neuropsychiatric disorders such as schizophrenia. These scientific advances in turn have re-kindled a great interest and demand for post-mortem brain tissue. Good quality post-mortem tissue undoubtedly is the fundamental prerequisite to investigate complex brain disorders with molecular profiling techniques. In this review we show that post-mortem brain tissue can yield good quality mRNA and intact protein antigens which allow the successful application of traditional molecular biology methods as well as novel profiling techniques. We also consider the use of laser-capture microdissection on post-mortem tissue. This recently developed technique allows the experimenter to explore the molecular basis of cellular function at the single cell level. The combination of laser-capture microdissection with high throughput profiling techniques offers opportunities to obtain precise genetic fingerprints of individual neurons allowing comparisons of normal and pathological states.


Subject(s)
Brain/metabolism , Gene Expression Profiling/methods , Gene Expression Profiling/trends , Neurodegenerative Diseases/genetics , RNA, Messenger/analysis , Autopsy/instrumentation , Autopsy/methods , Brain/pathology , Brain/physiopathology , Dissection/instrumentation , Dissection/methods , Dissection/trends , Gene Expression Profiling/instrumentation , Humans , Lasers , Neurodegenerative Diseases/metabolism , Neurodegenerative Diseases/physiopathology , Postmortem Changes
12.
Trends Neurosci ; 24(5): 277-82, 2001 May.
Article in English | MEDLINE | ID: mdl-11311380

ABSTRACT

The molecular nature of the metabotropic GABA(B) receptor was for some time a mystery, however it was recently discovered that two related G-protein-coupled receptors have to heterodimerize to form the functional GABA(B) receptor at the cell surface. This review discusses the most recent findings in the rapidly expanding field of GABA(B) receptor research, and includes a summary of all splice variants of both receptor subunits identified to date. It also evaluates emerging evidence that certain splice variants might play a role in determining pharmacologically distinguishable receptors, and reviews receptor localization at the sub-cellular level and involvement in neuronal development.


Subject(s)
Alternative Splicing/physiology , Neurons/chemistry , Neurons/physiology , Receptors, GABA-B/chemistry , Receptors, GABA-B/genetics , Animals , Humans
13.
Brain Res Mol Brain Res ; 88(1-2): 37-53, 2001 Mar 31.
Article in English | MEDLINE | ID: mdl-11295230

ABSTRACT

Antisera directed against unique peptide regions from each of the human brain voltage-gated sodium channel alpha subunits were generated. In immunoblots these were found to be highly specific for the corresponding recombinant polypeptides and to recognise the native holoprotein in human brain membrane preparations. These antisera were used to perform a comparative immunohistochemical distribution analysis of all four brain sodium channel subtypes in selected human CNS regions. Distinct but heterogeneous distribution patterns were observed for each of the alpha subunits. In general, these were complimentary to that previously shown for the corresponding human mRNAs. A high degree of conservation with respect to the distribution found in rat was also evident. The human alpha subunit proteins exhibited distinct subcellular localisation patterns. Types I, III and VI immunoreactivity was predominantly in neuronal cell bodies and proximal processes, whereas type II was concentrated along axons. This is similar to rat brain and suggests the different the sodium channel subtypes have distinct functions which are highly conserved between human and rodents. A notable difference was that the type III protein was detected in all human brain regions examined, unlike in rat brain where expression in adults is very restricted. Also in contrast to rat brain, the human type VI protein was not detected in axons of unmyelinated neurons. These differences may reflect true species variation and could have important implications for understanding the function of the sodium channel subtypes and their roles in human disease.


Subject(s)
Brain Chemistry , Sodium Channels/analysis , Adult , Aged , Aged, 80 and over , Animals , Antibody Specificity , Female , Humans , Ion Channel Gating , Male , Membrane Potentials , Middle Aged , Neurites/chemistry , Rabbits , Sodium Channels/immunology
14.
Brain Res Mol Brain Res ; 83(1-2): 72-80, 2000 Nov 10.
Article in English | MEDLINE | ID: mdl-11072097

ABSTRACT

Following the recent discovery that GABA(B) receptors expressed in cell lines are only functional when both GABA(B1) and GABA(B2) are expressed, the present study reports on the development of polyclonal antisera specific for carboxyl-terminal portions of the two related GABA(B) receptor components respectively. Western blotting indicated the specificity of affinity-purified antibodies for native or recombinant expressed GABA(BR1) and GABA(BR2), with no cross-reactivity, both antisera detecting the heterodimer in rat cerebellar membranes. Immunohistochemistry revealed a distinct distribution of both receptor proteins in rat cerebellum. GABA(B1) immunoreactivity was primarily located in the granule cell layer and Purkinje cells, with discrete immuno-positive cell bodies being present in the molecular layer. GABA(B2) staining revealed intense immunoreactivity in the molecular layer, with weaker staining in the granule cell layer. Purkinje cell bodies were less intensely immuno-positive for GABA(B2). Co-localisation of both receptor proteins was observed using double immunofluorescence techniques, consistent with the notion that both proteins are required for the formation of functional GABA(B) receptors in vivo. Immunofluorescence also indicated that GABA(B) receptors did not co-localise with glial fibrillary acid protein, confirming a neuronal localisation for GABA(B) receptors. Electron microscopic analysis of the molecular layer revealed that the distribution of immunolabelling for both GABA(B1) and GABA(B2) was mainly located on the membrane of Purkinje cell dendrites and spines and in parallel fibre terminals.


Subject(s)
Cerebellum/chemistry , Purkinje Cells/chemistry , Receptors, GABA-B/analysis , Animals , Antibody Specificity , Blotting, Western , Cerebellum/cytology , Cross Reactions , Immunohistochemistry , Male , Microscopy, Immunoelectron , Purkinje Cells/ultrastructure , Rabbits , Rats , Rats, Wistar , Receptors, GABA/analysis , Receptors, GABA/immunology , Receptors, GABA-B/immunology , Sheep , Tissue Embedding
15.
Proc Natl Acad Sci U S A ; 97(25): 13967-72, 2000 Dec 05.
Article in English | MEDLINE | ID: mdl-11087824

ABSTRACT

gamma-Aminobutyric acid type B (GABA(B)) receptors mediate the metabotropic actions of the inhibitory neurotransmitter GABA. These seven-transmembrane receptors are known to signal primarily through activation of G proteins to modulate the action of ion channels or second messengers. The functional GABA(B) receptor is made up of a heterodimer consisting of two subunits, GABA(B)-R1 and GABA(B)-R2, which interact via coiled-coil domains in their C-terminal tails. By using a yeast two-hybrid approach, we have identified direct interactions between the C-terminal tails of GABA(B)-R1 and GABA(B)-R2 with two related transcription factors, CREB2 (ATF4) and ATFx. In primary neuronal cultures as well in recombinant Chinese hamster ovary cells expressing GABA(B) receptors, CREB2 is localized within the cytoplasm as well as the nucleus. Activation of the GABA(B) receptor by the specific agonist baclofen leads to a marked translocation and accumulation of CREB2 from the cytoplasm into the nucleus. We demonstrate that receptor stimulation results in activation of transcription from a CREB2 responsive reporter gene. Such a signaling mechanism is unique among Family C G protein-coupled receptors and, in the case of the GABA(B) receptor and CREB2, may play a role in long-term changes in the nervous system.


Subject(s)
Nerve Tissue Proteins/metabolism , Receptors, GABA-B/metabolism , Repressor Proteins , Transcription Factors/metabolism , Amino Acid Sequence , Animals , Baclofen/pharmacology , CHO Cells , Cricetinae , Cyclic AMP Response Element-Binding Protein , Humans , Molecular Sequence Data , Precipitin Tests , Protein Binding , Subcellular Fractions/metabolism , Transcriptional Activation/drug effects
16.
Brain Res Mol Brain Res ; 82(1-2): 114-25, 2000 Oct 20.
Article in English | MEDLINE | ID: mdl-11042364

ABSTRACT

Somatostatin is known to have diverse neurophysiological effects in the mammalian CNS. To date, genes for five different receptors, termed sst(1-5), have been isolated. Recently several reports have been published on the localisation of the individual receptor protein in the rat CNS, but their localisation in the human CNS remains largely unknown. Until now little information about the function of the sst(4) receptor is available, and there is a lack of receptor specific agonists and antagonists. Here, we report for the first time the immunohistochemical localisation of the sst(4) receptor in selected human brain areas using an anti-peptide antibody raised against a carboxy-terminal portion of the receptor protein. Strong receptor immunoreactivity was found in several brain regions, including the hippocampal formation, the cerebellar cortex and the medulla. Further immunohistochemical labelling was observed in the cerebral cortex, the red nucleus and the globus pallidus. Somatodendritic as well as axonal staining was observed. Specific signals were entirely absent following antibody pre-adsorption with the synthetic peptide. The results are in good agreement with the previously published immunohistochemical localisation of the sst(4) receptor in the rat brain. This is the first immunohistochemical study of the localisation of the sst(4) receptor in the human brain, and implicates this receptor in the function of higher centres of the human nervous system.


Subject(s)
Brain/metabolism , Neurons/metabolism , Receptors, Somatostatin/metabolism , Adult , Aged , Aged, 80 and over , Brain/cytology , Female , Humans , Immunohistochemistry , Male , Membrane Proteins , Middle Aged , Neurons/cytology , Organ Specificity , Protein Isoforms/analysis , Receptors, Somatostatin/analysis
17.
Neuroreport ; 11(14): 3133-7, 2000 Sep 28.
Article in English | MEDLINE | ID: mdl-11043537

ABSTRACT

A number of studies have suggested that disturbance in glutamatergic transmission in the cerebral cortex may underlie, or contribute to the pathophysiology of schizophrenia. In this study we examined expression of the postsynaptic density protein 95 (PSD95) mRNA in the prefrontal cortex and hippocampus in postmortem material from neuroleptic-treated schizophrenics and normal controls. PSD95 is known to bind to NMDA receptor subunits and is known to be involved in synaptic plasticity. In situ hybridization analysis showed that the expression of PSD95 was significantly decreased in Brodmann area 9 of the prefrontal cortex but not in the hippocampus. These results further implicate the prefrontal cortex in the pathophysiology of schizophrenia and suggest dysfunction of NMDA receptors in the schizophrenic cortex.


Subject(s)
Glutamic Acid/metabolism , Hippocampus/metabolism , Nerve Tissue Proteins/genetics , Prefrontal Cortex/metabolism , Receptors, N-Methyl-D-Aspartate/metabolism , Schizophrenia/genetics , Aged , Cerebellum/metabolism , Cerebellum/pathology , Cerebellum/physiopathology , Disks Large Homolog 4 Protein , Female , Gene Expression Regulation/physiology , Hippocampus/pathology , Hippocampus/physiopathology , Humans , Intracellular Signaling Peptides and Proteins , Male , Membrane Proteins , Middle Aged , Neuronal Plasticity/physiology , Neurons/cytology , Neurons/metabolism , Prefrontal Cortex/pathology , Prefrontal Cortex/physiopathology , RNA, Messenger/metabolism , Schizophrenia/metabolism , Schizophrenia/physiopathology , Synaptic Membranes/metabolism , Synaptic Transmission/physiology
18.
Regul Pept ; 90(1-3): 1-18, 2000 Jun 30.
Article in English | MEDLINE | ID: mdl-10828487

ABSTRACT

It has long been considered that somatostatin acts as a neuromodulator in the mammalian central nervous system but its precise physiological roles remain elusive. Early studies to identify somatostatin-binding sites revealed a widespread heterogeneous pattern, especially in the CNS. More recently, a family of somatostatin receptors have been identified, of which five genes (sst(1-5)) have been cloned. In this review, we discuss current data describing the localisation of the five receptor types. Recent progress in understanding their function has been made using high-affinity, selective receptor ligands and transgenic animal technology. Finally, the therapeutic potential for somatostatin receptor-selective compounds as analgesics is considered.


Subject(s)
Neurons/physiology , Receptors, Somatostatin/physiology , Somatostatin/physiology , Analgesia , Animals , Electrophysiology , Humans , Neurons/metabolism , RNA, Messenger , Receptors, Somatostatin/genetics , Receptors, Somatostatin/metabolism , Somatostatin/analogs & derivatives , Somatostatin/genetics , Somatostatin/metabolism , Tissue Distribution
19.
J Comp Neurol ; 422(1): 123-39, 2000 Jun 19.
Article in English | MEDLINE | ID: mdl-10842222

ABSTRACT

The distribution of mRNAs encoding voltage-gated sodium channel alpha subunits (I, II, III, and VI) and beta subunits (beta1 and beta2) was studied in selected regions of the human brain by Northern blot and in situ hybridisation experiments. Northern blot analysis showed that all regions studied exhibited heterogenous expression of sodium channel transcripts. In situ hybridisation experiments confirmed these findings and revealed a predominantly neuronal distribution. In the parahippocampal gyrus, subtypes II and VI and the beta-subunit mRNAs exhibited robust expression in the granule cells of the dentate gyrus and pyramidal cell layer of the hippocampus. Subtypes I and III showed moderate expression in granule cells and low expression in the pyramidal cell layer. Distinct expression patterns were also observed in the cortical layers of the middle frontal gyrus and in the entorhinal cortex. In particular, all subtypes exhibited higher levels of expression in cortical layers III, V, and VI compared with layers I and II. All subtypes were expressed in the granular layer of the cerebellum, whereas specific expression of subtypes I, VI, beta1, and beta2 mRNAs was observed in Purkinje cells. Subtypes I, VI, and beta1 mRNAs were expressed, at varying levels, in the pyramidal cells of the deep cerebellar nuclei. These data indicate that, as in rat, human brain sodium channel mRNAs have a distinct regional distribution, with individual cell types expressing different compliments of sodium channels. The differential distribution of sodium channel subtypes suggest that they have distinct roles that are likely to be of paramount importance in maintaining the functional heterogeneity of central nervous system neurons.


Subject(s)
Cerebellum/metabolism , Cerebral Cortex/metabolism , Hippocampus/metabolism , RNA, Messenger/metabolism , Sodium Channels/metabolism , Animals , Humans , Ion Channel Gating , Rats
20.
Brain Res Dev Brain Res ; 121(1): 109-12, 2000 May 11.
Article in English | MEDLINE | ID: mdl-10837898

ABSTRACT

Tracing neural connectivity is important in understanding the intricacy of the nervous system as this represents the functional unit throughout the system. Here, we provide evidence that beta-galactosidase (beta-gal) linked to the N-terminal axonal translocation signal of GAP-43 provides a reproducible and versatile reporter system for analyzing the developing nervous system in vivo. When expressed by the GAP-43 promoter in transgenic mice, the fusion protein is detected equally within the developing axons of the peripheral and the central nervous systems, directly reflecting the promoter activity.


Subject(s)
Axons/metabolism , GAP-43 Protein/genetics , Galactosides/metabolism , Protein Sorting Signals/genetics , Animals , Galactosides/genetics , Ganglia, Sensory/embryology , Ganglia, Sensory/metabolism , Gene Expression Regulation, Developmental , Genes, Reporter , Growth Cones/metabolism , Lac Operon , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Mice, Transgenic
SELECTION OF CITATIONS
SEARCH DETAIL
...